Clopenthixol hydrochloride

This classification denotes the hydrochloride form of a dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0A432D932A. European Medicines Agency schedules Clopenthixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06736MIG. Clopenthixol generally arises in the molecular formula C22H25CLN2OS. The term CLOPENTHIXOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, list 5.) CLOPENTHIXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule clopenthixol hydrochloride under HS 29349990 and SITC 51579. SMILES: As of Q4 2014, CLOPENTHIXOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.